Related references
Note: Only part of the references are listed.Effects of a ketogenic diet in overweight women with polycystic ovary syndrome
Antonio Paoli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients with Obesity and Mild Kidney Failure
Adriano Bruci et al.
NUTRIENTS (2020)
Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
Panu K. Luukkonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Brain macroautophagy on the ketogenic diet
Daniela Liskiewicz et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2020)
Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study
Siew Lim et al.
BMC ENDOCRINE DISORDERS (2019)
Association between arginase-containing platelet-derived microparticles and altered plasma arginine metabolism in polycystic ovary syndrome
Anastasia Kyselova et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
Hector F. Escobar-Morreale
NATURE REVIEWS ENDOCRINOLOGY (2018)
Coronary artery disease risk in young women with polycystic ovary syndrome
Dah-Ching Ding et al.
Oncotarget (2018)
A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
Jia Wu et al.
REPRODUCTIVE HEALTH (2018)
High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance
J. Cai et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Ketogenic diet in endocrine disorders: Current perspectives
L. Gupta et al.
JOURNAL OF POSTGRADUATE MEDICINE (2017)
Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta analysis comparing products containing cyproterone acetate with third generation progestins
Mina Amiri et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Moderate doses of commercial preparations of Ginkgo biloba do not alter markers of liver function but moderate alcohol intake does: A new approach to identify and quantify biomarkers of 'adverse effects' of dietary supplements
Harris R. Lieberman et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
Annalisa Panico et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis
A. L. L. Rocha et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Helping Women Choose Appropriate Hormonal Contraception: Update on Risks, Benefits, and Indications
Abby L. Spencer et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
A. J. Goverde et al.
HUMAN REPRODUCTION (2009)
The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation
Masahide Hamaguchi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Cristian Cerda et al.
JOURNAL OF HEPATOLOGY (2007)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Share Paper
